✦ LIBER ✦

The conversion of d-xylose into d-threitol in patients without liver disease and in patients with portal liver cirrhosis

✍ Scribed by E. Pitkänen

Book ID: 115821730
Publisher: Elsevier Science
Year: 1977
Tongue: English
Weight: 418 KB
Volume: 80
Category: Article
ISSN: 0009-8981
DOI: 10.1016/0009-8981(77)90262-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vitamin D Deficiency in Patients with Ch

Vitamin D Deficiency in Patients with Chronic Liver Disease and Cirrhosis

✍ Lei Yuan Lim; Naga Chalasani 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 251 KB

The free portal pressure in awake patien

The free portal pressure in awake patients with and without cirrhosis of the liver

✍ Uffe Christensen; Thorkild I. A. Sørensen; Lise I. Jensen; Jan Aagaard; Flemming 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

Protein C and D-dimer are related to por

Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis

✍ Donglei Zhang; Jianyu Hao; Ning Yang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Relationship between the Fibrotest and p

Relationship between the Fibrotest and portal hypertension in patients with liver disease

✍ D. THABUT; F. IMBERT-BISMUT; D. CAZALS-HATEM; D. MESSOUS; M. MUNTENAU; D. C. VA 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 587 KB

Effect of cimetidine on portal pressure

Effect of cimetidine on portal pressure and systemic hemodynamics in patients with and without liver cirrhosis

✍ Nagasue, Naofumi ;Ogawa, Yuichiro ;Yukaya, Hirofumi ;Okita, Motoichi ;Yamamoto, 📂 Article 📅 1985 🏛 Springer-Verlag 🌐 English ⚖ 278 KB

Release of prostanoids into the portal a

Release of prostanoids into the portal and hepatic vein in patients with chronic liver disease

✍ Heinrich Wernze; Wolfgang Tittor; Matthias Goerig 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 758 KB

Arterial and hepatovenous concentrations of circulating prostaglandin Ez and prostaglandin Fzm, the stable metabolites of prostacyclin and thromboxane Az were measured in patients with chronic liver disease and compared with those in control patients with coronary artery disease but without hepatic